Published in Arthritis Rheum on December 01, 2003
Retracted Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol (2009) 3.84
Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice. Arthritis Rheum (2012) 2.21
C-type lectin-like receptor LOX-1 promotes dendritic cell-mediated class-switched B cell responses. Immunity (2014) 2.20
Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus. Arthritis Res Ther (2008) 2.15
B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome. Arthritis Res Ther (2006) 1.72
Persistent expression of autoantibodies in SLE patients in remission. J Exp Med (2006) 1.56
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. Arthritis Res Ther (2009) 1.54
Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production. Ann Rheum Dis (2006) 1.47
Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF. J Immunol (2006) 1.43
Autophagy: controlling cell fate in rheumatic diseases. Nat Rev Rheumatol (2016) 1.42
Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjögren's syndrome. J Clin Immunol (2005) 1.38
B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels. Arthritis Res Ther (2006) 1.36
Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther (2006) 1.34
T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus? Arthritis Res Ther (2014) 1.34
The search for lupus biomarkers. Best Pract Res Clin Rheumatol (2009) 1.26
B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis. J Clin Immunol (2009) 1.26
Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome. Ann Rheum Dis (2005) 1.24
BAFF: a local and systemic target in autoimmune diseases. Clin Exp Immunol (2009) 1.18
Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator. Proc Natl Acad Sci U S A (2007) 1.14
Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus. Arthritis Rheum (2010) 1.13
Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus. Ann Rheum Dis (2006) 1.12
Role of type I interferons in the activation of autoreactive B cells. Immunol Cell Biol (2012) 1.10
Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances. J Biomed Biotechnol (2010) 1.10
Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum (2011) 1.08
Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation. J Exp Med (2012) 1.08
B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia. Blood (2005) 1.06
BAFF is increased in renal transplant patients following treatment with alemtuzumab. Am J Transplant (2009) 1.06
Cytokines in systemic lupus erythematosus. Curr Mol Med (2009) 1.03
Generation and characterization of tabalumab, a human monoclonal antibody that neutralizes both soluble and membrane-bound B-cell activating factor. J Inflamm Res (2014) 1.00
APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis. Arthritis Res Ther (2012) 1.00
Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis (2004) 0.98
BAFF promotes Th17 cells and aggravates experimental autoimmune encephalomyelitis. PLoS One (2011) 0.97
Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand. Rheumatology (Oxford) (2010) 0.96
Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms. Arthritis Res Ther (2008) 0.95
Innate pathways to B-cell activation and tolerance. Ann N Y Acad Sci (2010) 0.95
Anticytokine therapies in systemic lupus erythematosus. Immunotherapy (2010) 0.94
FcgammaRIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation. Blood (2008) 0.93
Identification and validation of biomarkers associated with acute and chronic graft versus host disease. Bone Marrow Transplant (2015) 0.91
Enhanced rho-associated protein kinase activation in patients with systemic lupus erythematosus. Arthritis Rheum (2013) 0.91
Biological therapy for lupus nephritis-tribulations and trials. Nat Rev Rheumatol (2010) 0.90
Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis. Ann Rheum Dis (2004) 0.89
B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels. Arthritis Rheum (2011) 0.88
Biomarkers in systemic lupus erythematosus: challenges and prospects for the future. Ther Adv Musculoskelet Dis (2013) 0.88
Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor. Arthritis Rheum (2013) 0.87
The rationale for BAFF inhibition in systemic lupus erythematosus. Curr Rheumatol Rep (2012) 0.87
B cell-targeted therapies in autoimmunity: rationale and progress. F1000 Biol Rep (2009) 0.87
B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol (2015) 0.86
XRCC1 Arg399Gln gene polymorphism and the risk of systemic lupus erythematosus in the Polish population. DNA Cell Biol (2011) 0.85
Differential expression of BAFF and its receptors in discoid lupus erythematosus patients. J Dermatol Sci (2013) 0.85
FcγRIIb and BAFF differentially regulate peritoneal B1 cell survival. J Immunol (2012) 0.84
No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome. Arthritis Res Ther (2006) 0.84
BAFF and APRIL induce inflammatory activation of THP-1 cells through interaction with their conventional receptors and activation of MAPK and NF-κB. Inflamm Res (2011) 0.84
Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy. Lupus Sci Med (2015) 0.84
Synthetic peptides containing ITIM-like sequences of IREM-1 inhibit BAFF-mediated regulation of interleukin-8 expression and phagocytosis through SHP-1 and/or PI3K. Immunology (2011) 0.84
High-dose dexamethasone inhibits BAFF expression in patients with immune thrombocytopenia. J Clin Immunol (2009) 0.84
Effect of TACI signaling on humoral immunity and autoimmune diseases. J Immunol Res (2015) 0.84
Increased serum APRIL differentially correlates with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients. Rheumatol Int (2014) 0.83
[Recommendation for use of belimumab for systemic lupus erythematosus]. Z Rheumatol (2013) 0.83
Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren's syndrome: results of the BELISS study. Arthritis Res Ther (2015) 0.82
The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity. J Immunol (2014) 0.82
Expression of human endogenous retrovirus clone 4-1 may correlate with blood plasma concentration of anti-U1 RNP and anti-Sm nuclear antibodies. Clin Rheumatol (2005) 0.81
B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease. Dig Dis Sci (2016) 0.81
Hepatitis C Virus-related Mixed Cryoglobulinemia: Pathogenesis, Clinica Manifestations, and New Therapies. Gastroenterol Hepatol (N Y) (2007) 0.81
Blockade of B-cell-activating factor suppresses lupus-like syndrome in autoimmune BXSB mice. J Cell Mol Med (2009) 0.81
TLR tolerance reduces IFN-alpha production despite plasmacytoid dendritic cell expansion and anti-nuclear antibodies in NZB bicongenic mice. PLoS One (2012) 0.81
Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance. Arthritis Res Ther (2012) 0.81
Altered B cell signalling in autoimmunity. Nat Rev Immunol (2017) 0.80
Targeting B cells with biologics in systemic lupus erythematosus. Expert Opin Biol Ther (2010) 0.80
Belimumab in systemic lupus erythematosus: an update for clinicians. Ther Adv Chronic Dis (2012) 0.80
Belimumab: First targeted biological treatment for systemic lupus erythematosus. J Pharmacol Pharmacother (2011) 0.80
B cells and transplantation: an educational resource. Biol Blood Marrow Transplant (2009) 0.80
B cell activating factor (BAFF) and T cells cooperate to breach B cell tolerance in lupus-prone New Zealand Black (NZB) mice. PLoS One (2010) 0.80
Contribution of STAT4 gene single-nucleotide polymorphism to systemic lupus erythematosus in the Polish population. Mol Biol Rep (2012) 0.80
Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma. Open Rheumatol J (2008) 0.79
IL-18 105 A>C polymorphism contributes to renal manifestations in patients with SLE. Rheumatol Int (2009) 0.79
An update on belimumab for the treatment of lupus. Biologics (2011) 0.79
Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus. Int J Mol Sci (2015) 0.79
Dual B cell immunotherapy is superior to individual anti-CD20 depletion or BAFF blockade in murine models of spontaneous or accelerated lupus. Arthritis Rheumatol (2015) 0.79
Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials. Arthritis Res Ther (2015) 0.78
B-cell survival factors in autoimmune rheumatic disorders. Ther Adv Musculoskelet Dis (2015) 0.78
Perforin level in CD4+ T cells from patients with systemic lupus erythematosus. Rheumatol Int (2010) 0.77
Cutting Edge: BAFF Overexpression Reduces Atherosclerosis via TACI-Dependent B Cell Activation. J Immunol (2016) 0.76
Beyond transitional selection: New roles for BLyS in peripheral tolerance. Drug Dev Res (2011) 0.76
Targeting B cells in treatment of autoimmunity. Curr Opin Immunol (2016) 0.76
The BAFFling effects of rituximab in lupus: danger ahead? Nat Rev Rheumatol (2016) 0.76
γ-Secretase directly sheds the survival receptor BCMA from plasma cells. Nat Commun (2015) 0.76
B-cell-activating factor affects the occurrence of thyroid autoimmunity in chronic hepatitis C patients treated with interferon alpha. Clin Dev Immunol (2012) 0.76
Interferon-β1b increases Th2 response in neuromyelitis optica. Int J Mol Sci (2012) 0.76
Follicular Helper T Cells in Systemic Lupus Erythematosus: Why Should They Be Considered as Interesting Therapeutic Targets? J Immunol Res (2016) 0.75
Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date. Drug Des Devel Ther (2017) 0.75
Urinary B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL): potential biomarkers of active lupus nephritis. Clin Exp Immunol (2016) 0.75
BAFF (B cell activating factor) transcript level in peripheral blood of patients with SLE is associated with same-day disease activity as well as global activity over the next year. Lupus Sci Med (2015) 0.75
New treatment options for lupus - a focus on belimumab. Ther Clin Risk Manag (2012) 0.75
Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE). Pharmaceuticals (Basel) (2010) 0.75
Pathways leading to an immunological disease: systemic lupus erythematosus. Rheumatology (Oxford) (2017) 0.75
Monocyte chemoattractant protein-1 -2518 A/G single nucleotide polymorphism might be associated with renal disease and thrombocytopenia of SLE. J Biomed Biotechnol (2010) 0.75
Targeted genomic analysis reveals widespread autoimmune disease association with regulatory variants in the TNF superfamily cytokine signalling network. Genome Med (2016) 0.75
Effects of B-lymphocyte dysfunction on the serum copper, selenium and zinc levels of rheumatoid arthritis patients. Pak J Med Sci (2014) 0.75
Efficacy and safety of subcutaneous belimumab in systemic lupus erythematosus: A randomized, double-blind, placebo-controlled, 52-week study. Arthritis Rheumatol (2017) 0.75
Genome sequence of the palaeopolyploid soybean. Nature (2010) 17.82
DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol (2002) 6.85
A critical assessment of Mus musculus gene function prediction using integrated genomic evidence. Genome Biol (2008) 4.78
Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy. Hepatology (2009) 4.00
Enhanced computer vision with Microsoft Kinect sensor: a review. IEEE Trans Cybern (2013) 3.75
Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell (2005) 3.73
Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born. J Chem Theory Comput (2012) 3.40
Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res (2007) 3.40
Graph embedding and extensions: a general framework for dimensionality reduction. IEEE Trans Pattern Anal Mach Intell (2007) 3.06
Transcriptome dynamics of Deinococcus radiodurans recovering from ionizing radiation. Proc Natl Acad Sci U S A (2003) 2.52
Inferring gene regulatory networks from multiple microarray datasets. Bioinformatics (2006) 2.49
Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Arthritis Rheum (2003) 2.47
An integrated transcriptome atlas of the crop model Glycine max, and its use in comparative analyses in plants. Plant J (2010) 2.41
Visualization of nitric oxide in living cells by a copper-based fluorescent probe. Nat Chem Biol (2006) 2.33
Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum (2003) 2.21
Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse. Arthritis Rheum (2006) 2.17
Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators. J Immunol (2002) 2.16
Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase. J Med Chem (2008) 2.14
Crystal structure of BMP-9 and functional interactions with pro-region and receptors. J Biol Chem (2005) 2.03
Understanding the unique characteristics of suicide in China: national psychological autopsy study. Biomed Environ Sci (2005) 1.90
Clustering gene expression data using a graph-theoretic approach: an application of minimum spanning trees. Bioinformatics (2002) 1.81
Microarray analysis of chitin elicitation in Arabidopsis thaliana. Mol Plant Pathol (2002) 1.80
Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia. Epigenetics (2012) 1.80
BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases. J Immunol (2002) 1.77
Epidermal growth factor-like domain 7 protects endothelial cells from hyperoxia-induced cell death. Am J Physiol Lung Cell Mol Physiol (2007) 1.75
Evaluation of 50-mer oligonucleotide arrays for detecting microbial populations in environmental samples. Biotechniques (2004) 1.74
Epigenome-wide inheritance of cytosine methylation variants in a recombinant inbred population. Genome Res (2013) 1.72
Photoaffinity isolation and identification of proteins in cancer cell extracts that bind to platinum-modified DNA. Chembiochem (2009) 1.71
Global protein function annotation through mining genome-scale data in yeast Saccharomyces cerevisiae. Nucleic Acids Res (2004) 1.71
Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood (2007) 1.64
TIP, a T-cell factor identified using high-throughput screening increases survival in a graft-versus-host disease model. Nat Biotechnol (2003) 1.63
Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage. Hepatology (2010) 1.61
Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B. Clin Gastroenterol Hepatol (2010) 1.60
Musite, a tool for global prediction of general and kinase-specific phosphorylation sites. Mol Cell Proteomics (2010) 1.55
Comparisons among two fertile and three male-sterile mitochondrial genomes of maize. Genetics (2007) 1.53
The discovery and development of belimumab: the anti-BLyS-lupus connection. Nat Biotechnol (2012) 1.49
No supernovae associated with two long-duration gamma-ray bursts. Nature (2006) 1.47
CUBIC: identification of regulatory binding sites through data clustering. J Bioinform Comput Biol (2003) 1.47
catena-Poly[[bis(thiocyanato-kappa N)cadmium(II)]-di-mu-thiourea-kappa(4)S:S]. Acta Crystallogr C (2002) 1.45
SNP discovery by high-throughput sequencing in soybean. BMC Genomics (2010) 1.45
Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis. J Immunol (2007) 1.44
Preoperative rosuvastatin protects patients with coronary artery disease undergoing noncardiac surgery. Cardiology (2015) 1.43
MUFOLD: A new solution for protein 3D structure prediction. Proteins (2010) 1.42
Single feature polymorphism discovery in rice. PLoS One (2007) 1.42
Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects. Toxicol Sci (2006) 1.41
SoyDB: a knowledge database of soybean transcription factors. BMC Plant Biol (2010) 1.40
Characterizing loop dynamics and ligand recognition in human- and avian-type influenza neuraminidases via generalized born molecular dynamics and end-point free energy calculations. J Am Chem Soc (2009) 1.40
Prediction of novel miRNAs and associated target genes in Glycine max. BMC Bioinformatics (2010) 1.39
B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels. Arthritis Res Ther (2006) 1.36
Lupus nephritis: a critical review. Autoimmun Rev (2012) 1.36
PRIMEGENS-v2: genome-wide primer design for analyzing DNA methylation patterns of CpG islands. Bioinformatics (2008) 1.35
Computational identification of protein methylation sites through bi-profile Bayes feature extraction. PLoS One (2009) 1.34
Stevens-Johnson syndrome and toxic epidermal necrolysis. Autoimmun Rev (2008) 1.33
BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus. Arthritis Rheum (2005) 1.33
P3DB: a plant protein phosphorylation database. Nucleic Acids Res (2008) 1.31
Legume transcription factor genes: what makes legumes so special? Plant Physiol (2009) 1.30
Quantitative relationship between synonymous codon usage bias and GC composition across unicellular genomes. BMC Evol Biol (2004) 1.30
Soybean Knowledge Base (SoyKB): a web resource for soybean translational genomics. BMC Genomics (2012) 1.29
Transcriptional and physiological responses of Bradyrhizobium japonicum to desiccation-induced stress. J Bacteriol (2007) 1.29
Proteomic analysis of soybean root hairs after infection by Bradyrhizobium japonicum. Mol Plant Microbe Interact (2005) 1.27
Genomic and genetic evidence for the loss of umami taste in bats. Genome Biol Evol (2011) 1.27
Using Internet search engines to obtain medical information: a comparative study. J Med Internet Res (2012) 1.25
Genome-scale gene function prediction using multiple sources of high-throughput data in yeast Saccharomyces cerevisiae. OMICS (2004) 1.25
The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases. J Autoimmun (2008) 1.25
Understanding protein dispensability through machine-learning analysis of high-throughput data. Bioinformatics (2004) 1.24
A protocol for computer-based protein structure and function prediction. J Vis Exp (2011) 1.23
The immunobiology of systemic sclerosis. Semin Arthritis Rheum (2008) 1.22
Blockade of nonhormonal fibroblast growth factors by FP-1039 inhibits growth of multiple types of cancer. Sci Transl Med (2013) 1.21
Root hair systems biology. Trends Plant Sci (2010) 1.21
Genome-scale probe and primer design with PRIMEGENS. Methods Mol Biol (2007) 1.20
Mosaic: making biological sense of complex networks. Bioinformatics (2012) 1.19
A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23. Nat Genet (2013) 1.19
Homolog-specific PCR primer design for profiling splice variants. Nucleic Acids Res (2011) 1.19
PROSPECT II: protein structure prediction program for genome-scale applications. Protein Eng (2003) 1.19
Visual event recognition in videos by learning from Web data. IEEE Trans Pattern Anal Mach Intell (2012) 1.18
Regulation of cellular oncosis by uncoupling protein 2. J Biol Chem (2002) 1.17
An oligonucleotide microarray resource for transcriptional profiling of Bradyrhizobium japonicum. Mol Plant Microbe Interact (2007) 1.17
Contrast-enhanced whole-heart coronary MRA at 3.0T for the evaluation of cardiac venous anatomy. Int J Cardiovasc Imaging (2010) 1.17
ProteinDBS: a real-time retrieval system for protein structure comparison. Nucleic Acids Res (2004) 1.17
Identification of miRNA from Porphyra yezoensis by high-throughput sequencing and bioinformatics analysis. PLoS One (2010) 1.15
Targeted bisulfite sequencing by solution hybrid selection and massively parallel sequencing. Nucleic Acids Res (2011) 1.15
Revisiting Libman-Sacks endocarditis: a historical review and update. Clin Rev Allergy Immunol (2009) 1.14
Establishment of a protein reference map for soybean root hair cells. Plant Physiol (2008) 1.14
Automated Tongue Feature Extraction for ZHENG Classification in Traditional Chinese Medicine. Evid Based Complement Alternat Med (2012) 1.12
Improving the performance of DomainParser for structural domain partition using neural network. Nucleic Acids Res (2003) 1.12
Quantitative assessment of relationship between sequence similarity and function similarity. BMC Genomics (2007) 1.12
Transcription profiling of soybean nodulation by Bradyrhizobium japonicum. Mol Plant Microbe Interact (2008) 1.11
Multilinear discriminant analysis for face recognition. IEEE Trans Image Process (2007) 1.11
Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells. Mol Cancer (2011) 1.11
BLyS and BLyS receptor expression in non-Hodgkin's lymphoma. Exp Hematol (2002) 1.09
Clinical features and prognosis in adult-onset Still's disease: a study of 104 cases. Clin Rheumatol (2010) 1.08
Soybean knowledge base (SoyKB): a web resource for integration of soybean translational genomics and molecular breeding. Nucleic Acids Res (2013) 1.08
The geo-epidemiology of temporal (giant cell) arteritis. Clin Rev Allergy Immunol (2008) 1.08
A computational method for assessing peptide- identification reliability in tandem mass spectrometry analysis with SEQUEST. Proteomics (2004) 1.08
Colchicine revisited. Ann N Y Acad Sci (2009) 1.07